Oricell Therapeutics Closes $110 Million Pre-IPO Financing to Accelerate Global Development of Solid Tumor CAR-T Therapies

B SHANGHAI, April 9, 2026 /PRNewswire/ — Oricell Therapeutics Holdings Limited (“Oricell”), a global clinical-stage biotechnology company pioneering innovative cancer immunotherapies, today announced the cumulative…
posteditor
posteditor
Articles: 16137

Other News